Document
IPR2017-01104, No. 2031-60 Exhibit - Exhibit 2031 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2031-60 Exhibit - Exhibit 2031 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2041-70 Exhibit - Exhibit 2041 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2041-70 Exhibit - Exhibit 2041 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2010-40 Exhibit - Exhibit 2010 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2010-40 Exhibit - Exhibit 2010 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound rev...
Cite Document
IPR2017-01104, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound revised May 20
+ More Snippets
Document
IPR2017-01104, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1009-8 Exhibit - Ex 1009 FDA Guideline on Sterile Drug Products Produced by Aseptic Processing June 1987, reprinted June 1991 and Feb 1997 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1006-5 Exhibit - Ex 1006 Desai et al, WO 1999000113, published Jan 7, 1999 Desai (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1006-5 Exhibit - Ex 1006 Desai et al, WO 1999000113, published Jan 7, 1999 Desai (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2007-37 Exhibit - Exhibit 2007 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2007-37 Exhibit - Exhibit 2007 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1003-29 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1003-29 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2043-72 Exhibit - Exhibit 2043 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2043-72 Exhibit - Exhibit 2043 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2044-73 Exhibit - Exhibit 2044 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2044-73 Exhibit - Exhibit 2044 (P.T.A.B. Jul. 12, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1012-11 Exhibit - Ex 1012 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Sixth Day of Trial, No 06 438 GMS, Dkt 624 D Del June 9, 2008 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1020-19 Exhibit - Ex 1020 US Application No 11553,339, Amendment in Response to Non Final Office Action dated Oct 27, 2009 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1020-19 Exhibit - Ex 1020 US Application No 11553,339, Amendment in Response to Non Final Office Action dated Oct 27, 2009 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 1028-28 Exhibit - Ex 1028 Camden, US Patent No 6,177,460 (P.T.A.B. Apr. 4, 2017)
Cite Document
IPR2017-01104, No. 1028-28 Exhibit - Ex 1028 Camden, US Patent No 6,177,460 (P.T.A.B. Apr. 4, 2017)
+ More Snippets
Document
IPR2017-01104, No. 2006-36 Exhibit - Exhibit 2006 (P.T.A.B. Jul. 12, 2017)
Cite Document
IPR2017-01104, No. 2006-36 Exhibit - Exhibit 2006 (P.T.A.B. Jul. 12, 2017)
+ More Snippets